With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Brian Peters started his new role as SVP of the AI Squared division at Apimeds Pharmaceuticals. Pharma market research firm Konovo named Tim Albury as CFO. Tenpoint Therapeutics announced the ...

BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...